Accessed November 2, 2017
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
these guidelines are updated on 16 February 2021
Please check the new guideline here
https://medbox.org/document/who-guidelines-for-malaria#GO
PLoS Med 10(1): e1001366. https://doi.org/10.1371/journal.pmed.1001366
Published: January 8, 2013
Oxford Policy Management (OPM) - APW with UNAIDS (thru TSF)
Report
A Project of the Joep Lange Institute July, 2018
Experiences from Indonesia, Kenya, Uganda and Ukraine
Research Article
PLOS Medicine | DOI:10.1371/journal.pmed.1002253 April 4, 2017
UNAIDS Joint United Nations Programme on HIV/AIDS